Beta Lactamase Mechanism Agains Beta Lactams

Introduction

Leaner should continuously maintain and shape their envelopes to accommodate enormous stresses they encounter in different niches and to run into physiological needs, such every bit growth and multiplication. Bacterial envelope is highly organized as a layer structure including cell wall, membrane(southward), and the possible space betwixt them. The structure of prison cell envelope varies in prokaryotes. In general, Gram-positive bacteria incorporate a thick layer of jail cell wall equally well as a layer of cytoplasmic membrane. However, Gram-negative leaner (east.g., Escherichia coli) typically comprise an outer membrane, an intervening periplasmic infinite where a thin layer of cell wall resides, and a layer of cytoplasmic membrane.

The bacterial jail cell wall is unique to bacteria and plays a critical office in maintaining cell integrity. In addition, the conserved cell wall components, such as monomeric disaccharide tetrapeptide, could serve equally a signal to trigger host immunologic or pathologic responses (Goldman et al., 1982; Melly et al., 1984; Viala et al., 2004; Watanabe et al., 2004; Dziarski and Gupta, 2005; Cloud-Hansen et al., 2006; Strober et al., 2006). Thus, given its significant role in bacterial pathophysiology, prison cell wall has been an effective target for developing various antimicrobials with dissimilar style of deportment, such as beta-lactam and glycopeptide antibiotics. Of these, beta-lactam antibiotics are the most commercially available antibiotics in the market place. Until 2010, beta-lactam antibiotics business relationship for sales of approximately 53% of the total antibody market worldwide (42 billion US dollars; Hamad, 2010). Beta-lactam antibiotics inhibit bacterial cell wall biosynthesis, consequently leading to cell lysis and decease. Specifically, beta-lactam antibiotics bind and acylate active site of penicillin-binding poly peptide (PBP), the enzyme essential for the biosynthesis of bacteria jail cell wall.

To counteract bactericidal outcome of beta-lactams, bacteria have rapidly evolved defense systems in which production of beta-lactamase is a major beta-lactam resistance mechanism. Bacterial resistance to beta-lactam antibiotics has become a worldwide health care trouble, equally exemplified past the recent emergence of wide-range beta-lactam resistant NDM-one (New Delhi metallo-beta-lactamase i) strains (Kumarasamy et al., 2010). Beta-lactamase is an enzyme that could hydrolyze beta-lactam ring, consequently deactivating beta-lactam antibiotics. In Gram-negative leaner, the beta-lactamase was unremarkably produced at very high concentration constitutively or by induction via direct interaction of beta-lactam antibody with regulatory system (e.m., MeBR1/MecI in Staphylococcus aureus; Kogut et al., 1956; Richmond, 1963, 1965; Pollock, 1965; Zhu et al., 1992; Fuda et al., 2005; Safo et al., 2005). In Gram-negative bacteria, the expression level of beta-lactamase is usually low; however, information technology has been observed that product of beta-lactamase was inducible simply molecular basis for this phenomenon was not clear (Ambler, 1980; Jacobs et al., 1997).

In the past, extensive research has focused on the structure, function, and ecology of beta-lactamases while limited efforts were placed on the regulatory mechanisms of beta-lactamases. In 1990s, the induction of beta-lactamase AmpC was observed to be correlated to the recycling process of prison cell wall in Gram-negative leaner, which shed lite on the molecular basis of beta-lactamase induction (Jacobs et al., 1994). In the past two decades, accumulating evidence have shown the human relationship between muropeptide release and beta-lactamase induction in Gram-negative leaner (Holtje et al., 1994; Jacobs et al., 1994, 1997; Korsak et al., 2005). However, in Gram-positive bacteria, there is little evidence showing the induction of beta-lactamases by liberated murein fragments. Recently, Amoroso et al. (2012) observed that a cell wall fragment could re-enter in the cytoplasm of Bacillus licheniformis and office as a signal to induce the expression of beta-lactamase. However, whether this jail cell wall fragment is the major indicate for beta-lactamase induction in this Gram-positive bacterium notwithstanding needs to exist determined in the hereafter. Given the lack of information on the relationship betwixt beta-lactamase consecration and cell wall metabolism in Gram-positive bacteria, in this review, we only summarize the relevant background information and recent research on the mechanisms of beta-lactamase induction by cell wall fragments in Gram-negative bacteria. In improver, we also discuss potential strategies to mitigate beta-lactam resistance by targeting beta-lactamase induction pathways.

Peptidoglycan Biosynthesis and Recycling

In Gram-negative leaner, peptidoglycan (PG), also called murein, is a mesh construction with units of continuous biopolymer residing on the intervening space between the outer and inner (cytoplasmic) membrane. Specifically, PG is a polysaccharide composed of repeating β-(one,four)-GlcNAc-β-(1,4)-MurNAc disaccharide interconnected past oligopeptide stems via covalent bail (Glauner et al., 1988; Effigy 1). The PG maintains cell integrity by sustaining internal osmotic pressure level and keeps the regular bacterial shape. The glycan strand in E. coli is averagely composed of 29 disaccharide-peptide units (Glauner, 1988).

Figure 1. Schematic structure of PG and target sites of different enzymes (pointed by colour arrows). The synthetic enzyme (PBP) is highlighted in red while the lytic enzymes (NagZ, AmpD, and LT) are highlighted in blue. Notably, NagZ and AmpD catalyze the liberated muropeptides instead of intact PG. Hexagons denote sugars while rectangles announce stem amino acids. The cross-linkage between the height and bottom glycan strands is D-Ala → meso-A2pm. LT, lytic transglycosylase; PBP, penicillin-binding protein, chiliad-A2pm, meso-diaminopimelic acid; AnhMurNAc, i,vi-anhydro-MurNAc; β1 → 4, β-(ane,four)-glycosidic bond.

The PG biosynthesis involves multi-phase enzymatic activities. First, the PG monomer unit (disaccharide with oligopeptide stem) is attached to a lipid in the cytoplasmic leaf of inner membrane (van Heijenoort, 2001b; Barreteau et al., 2008; Bouhss et al., 2008). 2nd, the PG monomer-lipid intermediate is flipped into periplasm and catalyzed into the cease of extending glycan chain by glycosyltransferases (Goffin and Ghuysen, 1998; van Heijenoort, 2001a; Sauvage et al., 2008). Finally, the stalk oligopeptides [Fifty-Ala-γ-D-Glu-meso-A2pm-(L)-D-Ala-D-Ala pentapeptide in E. coli, Figure one] that is linked to MurNAc are cantankerous-linked to the next stem oligopeptides from other glycan chains by transpeptidases (Goffin and Ghuysen, 2002; Sauvage et al., 2008). These transpeptidases are the target of beta-lactam antibiotics and also chosen PBPs (including PBP1a, PBP1b, PBP1c, PBP2, and PBP3; Goffin and Ghuysen, 1998; Sauvage et al., 2008). Thus, PBPs are involved in the final phase of PG synthesis. Each bacterial prison cell may produce dissimilar PBPs, leading to diverse types of cantankerous-linkage, such every bit D-Ala → (D-meso-A2pm, (L)-meso-A2pm → (D)-meso-A2pm, and and so on (van Heijenoort, 2011), for making a rigid mesh structure of PG.

Notably, PG is not a static biological structure. The structural units of PG changes dynamically during bacterial growth and doubling, with sometime units degraded and new materials added. Instead of starting over the consummate de novo synthesis equally described above, big quantities of the new materials added are recycled from the degraded PG units. Information technology'south estimated that upward to lx% of the parental cell wall is made of the recycled PG units during active bacterial growth (de Pedro et al., 2001; Park and Uehara, 2008).

The PG recycling also involves multi-stage enzymatic activities. Starting time, the lytic transglycosylase (LT) cleaves the glycan strand between the MurNAc and GlcNAc, and forms the 1,6-anhydro bond at the newly exposed MurNAc end in the mean time. With the assistance of the endopeptidases (e.g., PBP4) that could suspension the cross-linkage betwixt stem oligopeptides, anhydro muropeptide monomers (GlcNAc-anhydro-MurNAc-peptides) are liberated from PG. The master muropeptides are GlcNAc-anhMurNAc-Fifty-Ala-γ-D-Glu-meso-A2pm-D-Ala (GlcNAc-anhydroMurNAc-tetrapeptide), with pocket-size corporeality of tri-, pentapeptides (Glauner, 1988). Second, these muropeptides are transported into cytoplasm through the inner membrane transporter AmpG (Park and Uehara, 2008). Afterwards, in cytoplasm, the GlcNAc saccharide residue is removed by the glycoside hydrolase NagZ (Cheng et al., 2000; Votsch and Templin, 2000). The resulting population of 1,half dozen-anhydroMurNAc-oligopeptides are further transformed to UDP-MurNAc-pentapeptide (Park and Uehara, 2008), a PG precursor that tin be reincorporated into the PG biosynthesis pathway (Park and Uehara, 2008). The muropeptides as well could serve as a signal to induce the production of beta-lactamase, which will be discussed beneath in Department "Mechanisms of Beta-lactamase Induction."

Beta-Lactam Antibiotics and Beta-Lactamase

In 1928, Alexander Fleming observed the bactericidal outcome of Penicillium notatum, leading to the identification of the showtime beta-lactam antibiotic, penicillin (Fleming, 1929). Since then, a variety of beta-lactam antibiotics with dissimilar antimicrobial profiles take been discovered or synthesized, such as penicillin derivatives (penams), cephalosporins (cephems), monobactams, and carbapenems. All beta-lactam antibiotics share a mutual core containing a iv-fellow member beta-lactam ring (Figure 2). This beta-lactam ring displays astounding structural mimicry with the backbone of the D-alanyl-D-alanine, the substrate of PBP (Figure 2). Therefore, penicillin has been proposed to act as a substrate analog and binds to the agile site of transpeptidases for inhibition of synthesis of the cross-linked PG (Tipper and Strominger, 1965). This hypothesis was later supported by the evidence that transpeptidases could bind radioactive-labeled penicillin; thus, transpeptidases were also called as PBPs (Cooper et al., 1949; Maass and Johnson, 1949a, 1949b; Cooper, 1955; Schepartz and Johnson, 1956; Markov et al., 1960; Spratt and Pardee, 1975).

FIGURE 2. The mimicry of beta-lactam antibiotics to D-alanyl-D-alanine (D-Ala-D-Ala). The four-fellow member lactam band in penicillin was highlighted in crimson.

Beta-lactam antibiotics have been a chief choice for physicians to treat bacterial infections due to their high specificity and potent killing upshot. Clinical introduction of beta-lactam antibiotics has ever claimed to be a historical victory against bacterial infection; the mortality rate due to bacterial infections in the USA was drastically dropped from 797 to 36 per 100,000 individuals between 1900 and 1980 (Armstrong et al., 1999). The emergence of antibiotic resistant bacteria quickly becomes the ghost of modern medicine (Cohen, 2000). In fact, even during the footing-breaking discovery of penicillin, Alexander Fleming has already isolated the E. coli, Salmonella enterica serovar Typhi, and Haemophilus influenza strains that were resistant to penicillin (Fleming, 1929). Although numerous efforts have been placed on the discovery new generation of beta-lactam antibiotics to farther improve their clinical efficacy, leaner accept been evolving with an unbeatable step to fail those new beta-lactams (Culotta, 1994). To address this serious public health issue, it is imperative to study the molecular basis of beta-lactam resistance so that we tin can overcome beta-lactam resistance by targeting resistance mechanisms.

The molecular mechanisms of beta-lactam resistance accept been widely studied (Ogawara, 1981; Fuda et al., 2004; Jovetic et al., 2010; Harris and Ferguson, 2012). To evade the bactericidal effects of beta-lactam antibiotics, Gram-negative bacteria have evolved multiple strategies, such as production of beta-lactamases (Korfmann and Wiedemann, 1988; Jacoby, 2009), production of novel PBPs with reduced analogousness to beta-lactam antibiotics (Fuda et al., 2004), reducing beta-lactam antibiotics entry through mutations in porins, and expelling beta-lactam antibiotics out of cells using multi-drug efflux pumps (Kohler et al., 1999). Of these mechanisms, producing beta-lactamases, the enzymes that could hydrolyze beta-lactam band, is notwithstanding the most efficient strategy (Abraham and Chain, 1940; Jacoby and Munoz-Toll, 2005). It has been proposed that beta-lactamases and the PBPs may share a mutual ancestor due to the presence of certain sequence homology (Massova and Mobashery, 1998). Recently, Fernandez et al. (2012) observed that overexpression beta-lactamases changed the PG composition and affected bacterial fitness, likely due to the rest transpeptidase activity of the beta-lactamases.

Given the tight link betwixt beta-lactam resistance and the beta-lactamase activity, information technology is not surprising that past studies were primarily focused on the structure, function, and environmental of beta-lactamases. Specially, many epidemiological, clinical, and ecological studies are focused on the detection and label of specific beta-lactamase genes with little attention on the regulatory machinery of beta-lactamases. The first "ambiguous" beta-lactamase, AmpC (originally named AmpA), was identified in beta-lactam sensitive East. coli M-12 past stepwise selection on beta-lactam antibiotics containing medium (Eriksson-Grennberg et al., 1965; Eriksson-Grennberg, 1968). The beta-lactam resistant derivatives constitutively produced high-level of beta-lactamases, suggesting the presence of an inducible beta-lactamase gene in E. coli K-12 (Linstrom et al., 1970). Subsequently, the AmpC gene was cloned and characterized as a beta-lactamase (Jaurin and Grundstrom, 1981). The expression of ampC ordinarily is maintained at depression level and dependent on growth rate (Jaurin et al., 1981). However, a single nucleotide mutation in the promoter region (probable an attenuator) of ampC led to overexpression of beta-lactamase, indicating that the ampC was subjected to regulation (Jaurin et al., 1981). Then the ampC was observed to be widely distributed in unlike enterobacterial species, such as Salmonella enterica serovar Typhimurium, Pseudomonas aeruginosa, Serratia marcescens, and Klebsiella pneumonia; interestingly, the ampC was inducible under treatment of beta-lactam antibiotics (Bergstrom et al., 1982). Nevertheless, the expression of ampC in E. coli was not induced past beta-lactam antibiotics due to the lack of a regulator gene ampR adjacent to the ampC in the chromosome (Honore et al., 1986). Complementation of Eastward. coli with a plasmid containing the ampR–ampC operon from Enterobacter cloacae restored the phenotype of beta-lactamase consecration (Kraft et al., 1999).

The induction of beta-lactamase is of smashing clinical importance. For instance, prolonged administration of beta-lactam antibiotics could atomic number 82 to emergence of P. aeruginosa mutants resistance to multiple beta-lactam antibiotics, eventually leading to treatment failure and patient death (Livermore, 1987; Sanders, 1987; Giwercman et al., 1990; Juan et al., 2005). Therefore, significant progresses have been fabricated on the molecular basis of the beta-lactamase consecration in Gram-negative bacteria in the past two decades.

Mechanisms of Beta-Lactamase Induction

Understanding the molecular basis of beta-lactamase consecration would facilitate us to develop constructive combination therapy strategy past inhibiting the consecration of beta-lactamase. Gram-negative bacteria have evolved ii major mechanisms for beta-lactamase induction, the AmpG–AmpR–AmpC pathway and the two-component regulatory system (TCRS; Effigy 3). Recent progresses in this significant inquiry surface area are summarized below.

FIGURE 3. The model of beta-lactamase induction in Gram-negative bacteria. The beta-lactamase induction past muropeptides via two major molecular mechanisms, the AmpG–AmpR–AmpC pathway and the BlrAB-like two-component regulatory organization, are presented. The signaling pathway via two-component regulatory system is but supported by limited studies to engagement and is shown in dashed arrows. The "Regulator" denotes AmpR-similar regulator or two-component response regulator. The "beta-lactamase" denotes the beta-lactamase that is subjected to induction. E, extracellular environment; OM, outer membrane; PS, periplasmic space; IM, inner membrane; C, cytoplasm.

The AmpG–AmpR–AmpC Pathway

As mentioned above, in many bacteria belonging to Enterobacteriaceae family, AmpC expression is induced by beta-lactam antibiotics. Since beta-lactam antibiotics treatment tin can trigger the release of large corporeality of muropeptides in periplasm, which could be subjected to cell wall recycling process, the human relationship between cell wall recycling and beta-lactamase induction has been examined and confirmed in recent studies. Briefly, in the AmpG–AmpR–AmpC pathway, beta-lactam antibiotics handling breaks the rest of PG biosynthesis (due east.1000., due to the inhibited PBP and the functional LT), consequently liberating GlcNAc-anhydro-MurNAc-oligopeptides in periplasm (Templin et al., 1992). The GlcNAc-anhydro-MurNAc-oligopeptides are farther transported into cytoplasm through AmpG transporter (Park and Uehara, 2008). The GlcNAc moiety is removed by enzyme NagZ, leading the accumulated PG products (mainly anhydro-MurNAc-tetrapeptides). In cytoplasm, anhydro-MurNAc-oligopeptide are the inducer of beta-lactamase expression through the interaction with AmpR (Lindquist et al., 1989; Jacobs et al., 1997).

AmpR is a LysR blazon transcriptional regulator and is encoded immediately upstream of ampC with opposite management (Lindquist et al., 1989; Jacobs et al., 1997). AmpR was demonstrated every bit an activator for ampC using in vitro transcription assay (Jacobs et al., 1997). However, production of ampC was still repressed even if bacterial host contains functional AmpR, unless exogenous beta-lactam antibiotic was added (Honore et al., 1986; Lindquist et al., 1989; Society et al., 1990; Jacobs et al., 1997). Therefore, information technology has been hypothesized that the activator function of AmpR was inhibited by certain cellular metabolite, which was demonstrated as the prison cell wall synthesis precursor, UDP-MurNAc-pentapeptide (Jacobs et al., 1997). This inhibition was abolished in the mutant with point mutation in AmpR (G102E; Bartowsky and Normark, 1991), indicating the role of the remainder G for the association of UDP-MurNAc-pentapeptide. Upon the handling of beta-lactam antibiotics, the accumulated intracellular anhydro-MurNAc-oligopeptides could readapt the AmpR-associated UDP-MurNAc-pentapeptide, triggering conformational change of AmpR, and subsequently activating the transcription of ampC (Jacobs et al., 1997). The DNase I-protection assay showed the binding site of AmpR was in a 39-bp region upstream of the ampC transcription start site (-40 to -88; Jacobs et al., 1997). Interestingly, AmpR in P. aeruginosa is a global transcriptional factor whose regulon includes beta-lactamases, proteases, quorum sensing, and other virulence factors (Kong et al., 2005; Balasubramanian et al., 2012).

Amongst the PG cycling process, there is a negative effector to fine-melody the expression of AmpC. A cytoplasmic N-acetylmuramoyl-L-alanine amidase, named AmpD (Holtje et al., 1994), could dissociate stem peptides from the anhydro-MurNAc or GlcNAc-anhydro-MurNAc, therefore, reducing concentrations of the inducing muropeptides and mitigating the overexpression of AmpC (Jacobs et al., 1994).

Consistent with these observations on the human relationship between PG cycling and beta-lactamase induction, perturbation of PG recycling also affected AmpC induction, suggesting potential pharmaceutical targets. For example, overproduction of the LT MltB stimulated beta-lactamase induction whereas specific inhibition of LT Slt70 by bulgecin repressed AmpC expression (Kraft et al., 1999). In addition, mutation of all six LT enzymes (Slt70, MltA, MltB, MltC, MltD, and EmtA) in E. coli decreased the beta-lactamase activities (Korsak et al., 2005).

Different versions of AmpG–AmpR–AmpC regulatory pathways exist in bacteria. For case, E. coli and Shigella spp. lacks an ampR gene (Bergstrom et al., 1982; Honore et al., 1986), leading to the low level, non-inducible expression of AmpC. The AmpC gene in Due east. coli was primarily regulated by an attenuator sequence in promoter region (Jaurin et al., 1981). The overexpression of AmpC tin exist achieved either past mutating attenuator (Jaurin et al., 1981) or by introducing an AmpR regulator (Kraft et al., 1999); the similar pathway was too observed in Acinetobacter baumannii (Bou and Martinez-Beltran, 2000). In Salmonella, the chromosomal AmpC–AmpR is usually absent-minded, which may be due to unbearable product toll of AmpC (Morosini et al., 2000). However, clinical Salmonella strains can acquire AmpC–AmpR through horizontally transferred mobile elements (Barnaud et al., 1998). In Serratia marcescens, besides AmpR regulation, the mail-transcriptional regulation too influences the expression of AmpC. Specifically, the half-life of ampC transcript could exist afflicted by a 126-bp, non-encoding region that forms a stem-loop structure (Mahlen et al., 2003). In P. aeruginosa PAO1, interestingly, at that place are 3 copies of ampD genes, which contributed to the stepwise up-regulation of AmpC with the discrete mutation of each copy of ampD (Juan et al., 2006).

The BlrAB-Like 2-Component Regulatory System

The TCRS, which involves sensing specific environmental stimuli (Capra and Laub, 2012), was also observed to be involved in the induction of beta-lactamase. In Aeromonas spp., the AmpC and two other chromosomally encoded beta-lactamases were regulated by the response regulator BlrA of a TCRS instead of an AmpR-blazon regulator (Alksne and Rasmussen, 1997). Complementation report demonstrated that overexpression of BlrA in E. coli enhanced the expression of the Aeromonas-derived beta-lactamase in E. coli MC1061 while the beta-lactamase was expressed at low level in the absenteeism of BlrA (Alksne and Rasmussen, 1997).

The closest TCRS homolog of BlrAB in E. coli is CreBC (Amemura et al., 1986; Wanner and Wilmes-Riesenberg, 1992). Interestingly, the beta-lactamases from Aeromonas hydrophila could be regulated by the CreBC TCRS system in the Cre⁺ E. coli strain such equally DH5α (Avison et al., 2000, 2001). The "cre/blr-tag" signature, which is the "TTCACnnnnnnTTCAC" motif located in the promoter of Cre-regulon, was identified in E. coli (Avison et al., 2001). These "cre/blr-tag" too reside in promoters of Aeromonas-derivative beta-lactamases (Niumsup et al., 2003), and the induction of those beta-lactamases by overexpressed BlrA was dependent on the presence of "cre/blr-tag" (Avison et al., 2004). In P. aeruginosa, inactivation of a non-essential PBP was shown to trigger overproduction of a chromosomal AmpC factor and this overproduction is dependent on CreBC TCRS (Moya et al., 2009). Interestingly, among the 32 tested E. coli TCRS response regulators, overexpression of FimZ conferred increased level of beta-lactam resistance through the action of AmpC in E. coli (Hirakawa et al., 2003).

Despite above show showing that TCRS is likewise involved in the consecration of beta-lactamase, the identity of the respective cues to which the TCRS respond for beta-lactamase induction is still unknown. We speculate that specific degraded PG components may serve every bit a signal for the response regulator to induce the production of beta-lactamase. This hypothesis needs to exist examined in the future.

Other Mechanisms

Another novel beta-lactamase induction pathway was discovered in Ralstonia pickettii (Girlich et al., 2006). The chromosomally encoded beta-lactamases (OXA-22 and OXA-60) were regulated by ORF-RP3 (short for RP3), a gene located at 192-bp upstream of the ATG codon of oxa-60. Inactivation of RP3 resulted in the abolishment of consecration of the both beta-lactamases; complementation of the RP3 restored the inducible expression of OXA-22 and OXA-60 (Girlich et al., 2006). DNase I footprinting showed that RP3 specifically bound to tandem repeats upstream at the transcriptional start sites of OXA-22 and OXA-60 genes, suggesting RP3 is a novel positive-regulator for beta-lactamase consecration (Girlich et al., 2009).

Pharmaceutical Implications of Beta-Lactamase Consecration Machinery

Discovery of beta-lactamase inhibitors is a promising strategy to combat the prevalent beta-lactam resistance (Bush and Macielag, 2010; Harris and Ferguson, 2012). Withal, this approach is challenged past the variable affinity of the inhibitors to dissimilar beta-lactamases and by the overwhelming quantity of the beta-lactamases produced in resistant cells. Based on the information reviewed here, we propose that the signaling pathways of beta-lactamase induction offer a broad array of promising targets for the discovery of new antibacterial drugs used for combination therapies. The inhibitors targeting beta-lactamase induction pathway may foreclose the emergence of beta-lactam resistance and enhance the efficacy of clinical beta-lactam antibiotics, as what we have observed for the efflux pump inhibitors (Lomovskaya and Bostian, 2006). In supporting this hypothesis, the frequency of emergence of ceftazidime resistance in blrAB mutant in P. aeruginosa was below the detection limit (<1 × 10^{- 11}), which is far below that for the wild-blazon parent strain (3 × x^{- viii}; Moya et al., 2009).

The potential targets in the beta-lactamase induction pathway as well as the known inhibitors are summarized in Table ane. Several inhibitors have been identified for LTs that play a critical function in the initializing the PG cycling. The LT inhibitor bulgecin could induce jail cell lysis and morphology changes in the presence of beta-lactam antibiotics although bulgecin alone did not show any antibacterial activity against E. coli (Imada et al., 1982; Nakao et al., 1986; Bonis et al., 2012). The major molecular target of bulgecin was the soluble LT Slt70 (Templin et al., 1992). In a ii.eight-Å resolution crystallographic construction of Slt70-bulgecin complex, one single bulgecin molecule was found to be located in the active site of Slt70, indicating that bulgecin may act as an analog of an oxocarbenium ion intermediate in the reaction catalyzed by Slt70 (Thunnissen et al., 1995). The beta-hexosaminidase inhibitor N-acetylglucosamine thiazoline (NAG-thiazoline) was as well establish to inhibit the LT sMltB from P. aeruginosa (Reid et al., 2004a, b). Some other inhibitor, hexa-North-acetylchitohexaose, can inhibit the LT from bacteriophage lambda (Leung et al., 2001). Interestingly, a proteinaceous inhibitor of vertebrate lysozymes (Ivy), which has conserved CKPHDC motif, was also plant to control the autolytic activity of bacterial LTs (Clarke et al., 2010).

TABLE 1. The inhibitors targeting the beta-lactamase induction pathway.

Regarding other targets in beta-lactamase consecration pathway, PUGNAc and modified EtBuPUG tin inhibit the part of NagZ past the mimicry of the oxocarbenium ion-like transition state (Stubbs et al., 2007). Unlike PUGNAc that is too a potent inhibitor against homo O-GlcNAcase and beta-hexosaminidase, EtBuPUG displayed 100-fold selectivity toward to NagZ. The function of inner membrane permease AmpG in laboratory strains of P. aeruginosa can be inhibited by carbonyl cyanide m-chlorophenylhydrazone (CCCP), a full general inhibitor of proton motive force, consequently leading to an increased susceptibility to beta-lactam antibiotics (Cheng and Park, 2002; Zhang et al., 2010). However, it is important to mention that CCCP also targets other free energy-dependent systems, such equally drug efflux pump; thus, the linkage between reduced beta-lactam resistance and AmpG inhibition was not clearly demonstrated in these studies.

Although a panel of inhibitors that target the PG recycling pathway have been identified (Table 1), it is nonetheless largely unknown if these inhibitors repress the inducible beta-lactam resistance effectively in Gram-negative bacteria, consequently enhancing the efficacy of clinical beta-lactam antibiotics. This knowledge gap needs to be filled in the futurity. In addition, similar to all infectious affliction drug developments, discovery of a promising inhibitor targeting the beta-lactamase consecration pathway and conversion such inhibitor into a clinically useful therapeutic amanuensis are likely a lengthy and challenging process. Some key issues, such equally toxicity, stability, bioavailability, and production toll, must be addressed. Despite these challenges, information technology is imperative to develop clinically useful inhibitors to suppress beta-lactamase induction and enhance "shelf-life" of a wide spectrum of beta-lactam antibiotics against bacterial pathogens. To achieve this goal, in-depth structural and functional studies are needed for the potential targets (Table i), which is disquisitional for identifying corresponding inhibitors using various modern approaches, such as high-throughput screening of compound library, homology modeling and molecular docking.

Conflict of Interest Statement

The authors declare that the research was conducted in the absenteeism of any commercial or financial relationships that could be construed as a potential conflict of involvement.

Acknowledgments

Work in our laboratory was supported by University of Tennessee AgResearch and NIH Grant 1R56AI090095-01A1 (to Jun Lin).

Abbreviations

GlcNAc, Due north-acetylglucosamine; LT, lytic transglycosylase; MurNAc, Northward-acetylmuramic acrid; PBP, penicillin-binding protein; PG, peptidoglycan; TCRS, two-component regulatory system.

References

Abraham, Due east. P., and Concatenation, East. (1940). An enzyme from bacteria able to destroy penicillin. Nature 146, 837–837.

CrossRef Total Text

Alksne, L. E., and Rasmussen, B. A. (1997). Expression of the AsbA1, OXA-12, and AsbM1 beta-lactamases in Aeromonas jandaei AER 14 is coordinated by a two-component regulon. J. Bacteriol. 179, 2006–2013.

Pubmed Abstract | Pubmed Total Text

Amemura, K., Makino, 1000., Shinagawa, H., and Nakata, A. (1986). Nucleotide sequence of the phoM region of Escherichia coli: iv open up reading frames may constitute an operon. J. Bacteriol. 168, 294–302.

Pubmed Abstract | Pubmed Full Text

Amoroso, A., Boudet, J., Berzigotti, S., Duval, 5., Teller, N., Mengin-Lecreulx, D., et al. (2012). A peptidoglycan fragment triggers β-lactam resistance in Bacillus licheniformis. PLoS Pathog. 8:e1002571. doi: 10.1371/journal.ppat.1002571

Pubmed Abstract | Pubmed Full Text | CrossRef Total Text

Avison, G. B., Horton, R. East., Walsh, T. R., and Bennett, P. M. (2001). Escherichia coli CreBC is a global regulator of cistron expression that responds to growth in minimal media. J. Biol. Chem. 276, 26955–26961.

Pubmed Abstruse | Pubmed Full Text | CrossRef Total Text

Avison, Yard. B., Niumsup, P., Nurmahomed, One thousand., Walsh, T. R., and Bennett, P. Thou. (2004). Role of the 'cre/blr-tag' DNA sequence in regulation of cistron expression past the Aeromonas hydrophila beta-lactamase regulator, BlrA. J. Antimicrob. Chemother. 53, 197–202.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Avison, M. B., Niumsup, P., Walsh, T. R., and Bennett, P. Grand. (2000). Aeromonas hydrophila AmpH and CepH beta-lactamases: derepressed expression in mutants of Escherichia coli lacking creB. J. Antimicrob. Chemother. 46, 695–702.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Balasubramanian, D., Schneper, L., Merighi, K., Smith, R., Narasimhan, G., Lory, South., et al. (2012). The regulatory repertoire of Pseudomonas aeruginosa AmpC β-lactamase regulator AmpR includes virulence genes. PLoS 1 7:e34067. doi: x.1371/journal.pone.0034067

Pubmed Abstract | Pubmed Total Text | CrossRef Full Text

Barnaud, K., Arlet, M., Verdet, C., Gaillot, O., Lagrange, P. H., and Philippon, A. (1998). Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-ane) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 42, 2352–2358.

Pubmed Abstruse | Pubmed Total Text

Barreteau, H., Kovac, A., Boniface, A., Sova, M., Gobec, S., and Blanot, D. (2008). Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32, 168–207.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Bergstrom, Due south., Olsson, O., and Normark, S. (1982). Common evolutionary origin of chromosomal beta-lactamase genes in enterobacteria. J. Bacteriol. 150, 528–534.

Pubmed Abstract | Pubmed Full Text

Bonis, G., Williams, A., Guadagnini, Due south., Werts, C., and Boneca, I. G. (2012). The effect of bulgecin A on peptidoglycan metabolism and physiology of Helicobacter pylori. Microb. Drug Resist. 18, 230–239.

Pubmed Abstruse | Pubmed Full Text | CrossRef Total Text

Bou, G., and Martinez-Beltran, J. (2000). Cloning, nucleotide sequencing, and assay of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44, 428–432.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Cheng, Q., Li, H., Merdek, K., and Park, J. T. (2000). Molecular label of the beta-N-acetylglucosaminidase of Escherichia coli and its part in cell wall recycling. J. Bacteriol. 182, 4836–4840.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Clarke, C. A., Scheurwater, E. M., and Clarke, A. J. (2010). The vertebrate lysozyme inhibitor Ivy functions to inhibit the activity of lytic transglycosylase. J. Biol. Chem. 285, 14843–14847.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Cloud-Hansen, One thousand. A., Peterson, S. B., Stabb, E. V., Goldman, W. East., Mcfall-Ngai, M. J., and Handelsman, J. (2006). Breaching the groovy wall: peptidoglycan and microbial interactions. Nat. Rev. Microbiol. iv, 710–716.

Pubmed Abstruse | Pubmed Full Text | CrossRef Full Text

de Pedro, One thousand. A., Donachie, W. D., Holtje, J. V., and Schwarz, H. (2001). Constitutive septal murein synthesis in Escherichia coli with impaired activity of the morphogenetic proteins RodA and penicillin-binding poly peptide 2. J. Bacteriol. 183, 4115–4126.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Eriksson-Grennberg, K. One thousand., Boman, H. 1000., Jansson, J. A. T., and Thoren, S. (1965). Resistance of Escherichia coli to penicillins. I. Genetic report of some ampicillin-resistant mutants. J. Bacteriol. 90, 54–62.

Pubmed Abstract | Pubmed Full Text

Fernandez, A., Perez, A., Ayala, J. A., Mallo, S., Rumbo-Feal, Southward., Tomas, M., et al. (2012). Expression of OXA-blazon and SFO-1 beta-lactamases induces changes in peptidoglycan limerick and affects bacterial fitness. Antimicrob. Agents Chemother. 56, 1877–1884.

Pubmed Abstruse | Pubmed Full Text | CrossRef Full Text

Fleming, A. (1929). On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenza. Br. J. Exp. Pathol. x, 226–236.

Fuda, C., Suvorov, M., Vakulenko, Southward. B., and Mobashery, S. (2004). The basis for resistance to beta-lactam antibiotics past penicillin-bounden protein 2a of methicillin-resistant Staphylococcus aureus. J. Biol. Chem. 279, 40802–40806.

Pubmed Abstruse | Pubmed Total Text | CrossRef Full Text

Girlich, D., Kolb, A., Naas, T., and Nordmann, P. (2009). Characterization of regulatory element Rp3 of regulation of beta-lactamases from Ralstonia pickettii. FEMS Microbiol. Lett. 301, 50–56.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Giwercman, B., Lambert, P. A., Rosdahl, Five. T., Shand, Yard. H., and Hoiby, N. (1990). Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo pick of stable partially derepressed beta-lactamase producing strains. J. Antimicrob. Chemother. 26, 247–259.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Glauner, B., Holtje, J. V., and Schwarz, U. (1988). The composition of the murein of Escherichia coli. J. Biol. Chem. 263, 10088–10095.

Pubmed Abstract | Pubmed Full Text

Goffin, C., and Ghuysen, J. K. (1998). Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol. Mol. Biol. Rev. 62, 1079–1093.

Pubmed Abstract | Pubmed Full Text

Goffin, C., and Ghuysen, J. M. (2002). Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent. Microbiol. Mol. Biol. Rev. 66, 702–738; table of contents.

Pubmed Abstract | Pubmed Total Text | CrossRef Full Text

Goldman, West. E., Klapper, D. Thousand., and Baseman, J. B. (1982). Detection, isolation, and assay of a released Bordetella pertussis production toxic to cultured tracheal cells. Infect. Immun. 36, 782–794.

Pubmed Abstract | Pubmed Full Text

Harris, P. N., and Ferguson, J. K. (2012). Antibiotic therapy for inducible AmpC beta-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides? Int. J. Antimicrob. Agents xl, 297–305.

Pubmed Abstruse | Pubmed Full Text | CrossRef Full Text

Hirakawa, H., Nishino, K., Yamada, J., Hirata, T., and Yamaguchi, A. (2003). Beta-lactam resistance modulated by the overexpression of response regulators of 2-component point transduction systems in Escherichia coli. J. Antimicrob. Chemother. 52, 576–582.

Pubmed Abstruse | Pubmed Full Text | CrossRef Full Text

Holtje, J. V., Kopp, U., Ursinus, A., and Wiedemann, B. (1994). The negative regulator of beta-lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase. FEMS Microbiol. Lett. 122, 159–164.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Honore, N., Nicolas, Yard. H., and Cole, S. T. (1986). Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli. EMBO J. 5, 3709–3714.

Pubmed Abstract | Pubmed Full Text

Imada, A., Kintaka, K., Nakao, One thousand., and Shinagawa, Southward. (1982). Bulgecin, a bacterial metabolite which in concert with beta-lactam antibiotics causes bulge formation. J. Antibiot. (Tokyo) 35, 1400–1403.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Jacobs, C., Frere, J. M., and Normark, Due south. (1997). Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria. Cell 88, 823–832.

Pubmed Abstruse | Pubmed Full Text | CrossRef Full Text

Jacobs, C., Huang, L. J., Bartowsky, E., Normark, Due south., and Park, J. T. (1994). Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta-lactamase induction. EMBO J. xiii, 4684–4694.

Pubmed Abstruse | Pubmed Full Text

Jaurin, B., and Grundstrom, T. (1981). ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type. Proc. Natl. Acad. Sci. U.South.A. 78, 4897–4901.

Pubmed Abstract | Pubmed Total Text | CrossRef Full Text

Jovetic, Due south., Zhu, Y., Marcone, Chiliad. L., Marinelli, F., and Tramper, J. (2010). beta-Lactam and glycopeptide antibiotics: outset and last line of defense? Trends Biotechnol. 28, 596–604.

Pubmed Abstract | Pubmed Full Text | CrossRef Total Text

Juan, C., Gutierrez, O., Oliver, A., Ayestaran, J. I., Borrell, North., and Perez, J. L. (2005). Contribution of clonal broadcasting and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting. Clin. Microbiol. Infect. xi, 887–892.

Pubmed Abstract | Pubmed Total Text | CrossRef Total Text

Juan, C., Moya, B., Perez, J. L., and Oliver, A. (2006). Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves iii AmpD homologues. Antimicrob. Agents Chemother. 50, 1780–1787.

Pubmed Abstract | Pubmed Full Text | CrossRef Total Text

Kogut, M., Pollock, M. R., and Tridgell, Eastward. J. (1956). Purification of penicillin-induced penicillinase of Bacillus cereus NRRL 569: a comparing of its properties with those of a similarly purified penicillinase produced spontaneously by a constitutive mutant strain. Biochem. J. 62, 391–401.

Pubmed Abstract | Pubmed Full Text

Kohler, T., Michea-Hamzehpour, M., Epp, S. F., and Pechere, J. C. (1999). Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob. Agents Chemother. 43, 424–427.

Pubmed Abstruse | Pubmed Full Text

Kong, K. F., Jayawardena, Southward. R., Indulkar, S. D., Del Puerto, A., Koh, C. L., Hoiby, N., et al. (2005). Pseudomonas aeruginosa AmpR is a global transcriptional factor that regulates expression of AmpC and PoxB beta-lactamases, proteases, quorum sensing, and other virulence factors. Antimicrob. Agents Chemother. 49, 4567–4575.

Pubmed Abstract | Pubmed Full Text | CrossRef Total Text

Korsak, D., Liebscher, S., and Vollmer, W. (2005). Susceptibility to antibiotics and beta-lactamase consecration in murein hydrolase mutants of Escherichia coli. Antimicrob. Agents Chemother. 49, 1404–1409.

Pubmed Abstract | Pubmed Full Text | CrossRef Total Text

Kraft, A. R., Prabhu, J., Ursinus, A., and Holtje, J. V. (1999). Interference with murein turnover has no effect on growth only reduces beta-lactamase consecration in Escherichia coli. J. Bacteriol. 181, 7192–7198.

Pubmed Abstruse | Pubmed Full Text

Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., et al. (2010). Emergence of a new antibiotic resistance machinery in India, Pakistan, and the Uk: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10, 597–602.

Pubmed Abstract | Pubmed Total Text | CrossRef Full Text

Leung, A. One thousand., Duewel, H. Due south., Honek, J. F., and Berghuis, A. G. (2001). Crystal construction of the lytic transglycosylase from bacteriophage lambda in circuitous with hexa-N-acetylchitohexaose. Biochemistry 40, 5665–5673.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Lindquist, S., Lindberg, F., and Normark, S. (1989). Bounden of the Citrobacter freundii AmpR regulator to a single Dna site provides both autoregulation and activation of the inducible ampC beta-lactamase cistron. J. Bacteriol. 171, 3746–3753.

Pubmed Abstract | Pubmed Total Text

Linstrom, E. B., Boman, H. G., and Steele, B. B. (1970). Resistance of Escherichia coli to penicillins. VI. Purification and characterization of the chromosomally mediated penicillinase nowadays in ampA-containing strains. J. Bacteriol. 101, 218–231.

Pubmed Abstract | Pubmed Full Text

Guild, J. One thousand., Minchin, S. D., Piddock, L. J., and Busby, S. J. (1990). Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal ampC beta-lactamase. Biochem. J. 272, 627–631.

Pubmed Abstract | Pubmed Total Text

Maass, E. A., and Johnson, M. J. (1949b). The relations betwixt bound penicillin and growth in Staphylococcus aureus. J. Bacteriol. 58, 361–366.

Pubmed Abstract | Pubmed Full Text

Mahlen, S. D., Morrow, S. S., Abdalhamid, B., and Hanson, North. D. (2003). Analyses of ampC factor expression in Serratia marcescens reveal new regulatory properties. J. Antimicrob. Chemother. 51, 791–802.

Pubmed Abstract | Pubmed Total Text | CrossRef Total Text

Markov, Yard. I., Saev, G. K., and Ilkov, T. (1960). Investigations with the aid of radioactive isotopes of the issue of penicillin on metabolic processes in penicillin-resistant staphylococci. Suvr. Med. (Sofiia) 11, three–8.

Pubmed Abstract | Pubmed Full Text

Melly, Grand. A., Mcgee, Z. A., and Rosenthal, R. S. (1984). Ability of monomeric peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian-tube mucosa. J. Infect. Dis. 149, 378–386.

Pubmed Abstract | Pubmed Total Text | CrossRef Full Text

Morosini, M. I., Ayala, J. A., Baquero, F., Martinez, J. L., and Blazquez, J. (2000). Biological price of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob. Agents Chemother. 44, 3137–3143.

Pubmed Abstract | Pubmed Total Text | CrossRef Full Text

Moya, B., Dotsch, A., Juan, C., Blazquez, J., Zamorano, 50., Haussler, Southward., et al. (2009). β-Lactam resistance response triggered past inactivation of a nonessential penicillin-bounden protein. PLoS Pathog. v:e1000353. doi: x.1371/journal.ppat.1000353

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Nakao, 1000., Yukishige, Thou., Kondo, M., and Imada, A. (1986). Novel morphological changes in gram-negative leaner caused by combination of bulgecin and cefmenoxime. Antimicrob. Agents Chemother. 30, 414–417.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Niumsup, P., Simm, A. One thousand., Nurmahomed, K., Walsh, T. R., Bennett, P. One thousand., and Avison, M. B. (2003). Genetic linkage of the penicillinase factor, amp, and blrAB, encoding the regulator of beta-lactamase expression in Aeromonas spp. J. Antimicrob. Chemother. 51, 1351–1358.

Pubmed Abstract | Pubmed Full Text | CrossRef Total Text

Ogawara, H. (1981). Antibody resistance in pathogenic and producing leaner, with special reference to beta-lactam antibiotics. Microbiol. Rev. 45, 591–619.

Pubmed Abstract | Pubmed Full Text

Park, J. T., and Uehara, T. (2008). How bacteria consume their own exoskeletons (turnover and recycling of jail cell wall peptidoglycan). Microbiol. Mol. Biol. Rev. 72, 211–227; table of contents.

Pubmed Abstruse | Pubmed Full Text | CrossRef Full Text

Pollock, One thousand. R. (1965). Purification and backdrop of penicillinases from ii strains of Bacillus licheniformis: a chemical, physicochemical and physiological comparison. Biochem. J. 94, 666–675.

Pubmed Abstract | Pubmed Total Text

Reid, C. Westward., Blackburn, N. T., Legaree, B. A., Auzanneau, F. I., and Clarke, A. J. (2004b). Inhibition of membrane-spring lytic transglycosylase B by NAG-thiazoline. FEBS Lett. 574, 73–79.

Pubmed Abstract | Pubmed Full Text | CrossRef Total Text

Richmond, M. H. (1963). Purification and properties of the exopenicillinase from Staphylococcus aureus. Biochem. J. 88, 452–459.

Pubmed Abstract | Pubmed Full Text

Safo, M. Chiliad., Zhao, Q., Ko, T. P., Musayev, F. North., Robinson, H., Scarsdale, N., et al. (2005). Crystal structures of the BlaI repressor from Staphylococcus aureus and its complex with DNA: insights into transcriptional regulation of the bla and mec operons. J. Bacteriol. 187, 1833–1844.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Sauvage, E., Kerff, F., Terrak, Thou., Ayala, J. A., and Charlier, P. (2008). The penicillin-binding proteins: construction and role in peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32, 234–258.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Stubbs, K. A., Balcewich, G., Mark, B. 50., and Vocadlo, D. J. (2007). Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance. J. Biol. Chem. 282, 21382–21391.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Templin, Chiliad. F., Edwards, D. H., and Holtje, J. V. (1992). A murein hydrolase is the specific target of bulgecin in Escherichia coli. J. Biol. Chem. 267, 20039–20043.

Pubmed Abstract | Pubmed Total Text

Thunnissen, A. 1000., Rozeboom, H. J., Kalk, K. H., and Dijkstra, B. W. (1995). Structure of the 70-kDa soluble lytic transglycosylase complexed with bulgecin A. Implications for the enzymatic mechanism. Biochemistry 34, 12729–12737.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Tipper, D. J., and Strominger, J. L. (1965). Mechanism of activity of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine. Proc. Natl. Acad. Sci. The statesA. 54, 1133–1141.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, Due south. East., Moran, A. P., et al. (2004). Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5, 1166–1174.

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text

Votsch, Due west., and Templin, One thousand. F. (2000). Characterization of a beta-N-acetylglucosaminidase of Escherichia coli and elucidation of its part in muropeptide recycling and beta-lactamase consecration. J. Biol. Chem. 275, 39032–39038.

Pubmed Abstruse | Pubmed Total Text | CrossRef Full Text

Wanner, B. Fifty., and Wilmes-Riesenberg, M. R. (1992). Interest of phosphotransacetylase, acetate kinase, and acetyl phosphate synthesis in command of the phosphate regulon in Escherichia coli. J. Bacteriol. 174, 2124–2130.

Pubmed Abstract | Pubmed Total Text

Zhang, Y., Bao, Q., Gagnon, L. A., Huletsky, A., Oliver, A., Jin, S., et al. (2010). ampG gene of Pseudomonas aeruginosa and its function in beta-lactamase expression. Antimicrob. Agents Chemother. 54, 4772–4779.

Pubmed Abstruse | Pubmed Full Text | CrossRef Full Text

Zhu, Y., Englebert, S., Joris, B., Ghuysen, J. M., Kobayashi, T., and Lampen, J. O. (1992). Construction, function, and fate of the BlaR indicate transducer involved in induction of beta-lactamase in Bacillus licheniformis. J. Bacteriol. 174, 6171–6178.

Pubmed Abstract | Pubmed Full Text

dominguezalwyet48.blogspot.com

Source: https://www.frontiersin.org/articles/10.3389/fmicb.2013.00128/full

Share this post